• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-4722-5p和微小RNA-615-3p可作为阿尔茨海默病的潜在生物标志物。

MicroRNA-4722-5p and microRNA-615-3p serve as potential biomarkers for Alzheimer's disease.

作者信息

Liu Yan, Xu Yuhao, Yu Ming

机构信息

Department of Neurology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China.

出版信息

Exp Ther Med. 2022 Mar;23(3):241. doi: 10.3892/etm.2022.11166. Epub 2022 Jan 26.

DOI:10.3892/etm.2022.11166
PMID:35222718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8815048/
Abstract

The aim of the present study was to investigate the expression levels of microRNA(miR)-4722-5p and miR-615-3p in Alzheimer's disease (AD) and their diagnostic value. Blood samples were collected from 33 patients with AD and 33 healthy controls, and an β-amyloid (Aβ)25-35-induced PC12 cell model was also established. The relative mRNA expression levels of miR-4722-5p and miR-615-3p were detected using reverse transcription-quantitative PCR. The correlations between the mRNA expression levels of the two miRNAs and the mini-mental state examination (MMSE) scores were analyzed, and the receiver operating characteristic curve was used to assess the diagnostic value of miR-4722-5p and miR-615-3p in AD. Functional enrichment analysis of the miRNA target genes was performed using The Database for Annotation, Visualization and Integrated Discovery database and the R language analysis package. The mRNA expression levels of miR-4722-5p and miR-615-3p were increased in patients with AD and the Aβ25-35-induced PC12 cell model. The mRNA expression levels of miR-4722-5p and miR-615-3p were negatively correlated with MMSE scores, and the combination of the two miRNAs for AD had an improved diagnostic value than that of each miRNA alone. The results of Gene Ontology (GO) enrichment analysis showed that the target genes of miR-4722-5p were found in the cytoplasm and cytosol, and were mainly involved in protein folding and cell division. The molecular functions included protein binding and GTPase activator activity. The results of Kyoto Encyclopedia of Genes and Genomes analysis showed that miR-4722-5p was associated with the regulation of dopaminergic synapses and mTOR signaling pathways. GO enrichment analysis also revealed that the target genes of miR-615-3p were located in the nucleus and cytoplasm, were involved in the regulation of transcription and protein phosphorylation, and were associated with protein binding, metal ion binding and transcription factor activity. The target genes of miR-615-3p played important roles in the regulation of the Ras and FoxO signaling pathways. In conclusion, miR-4722-5p and miR-615-3p may be potential biomarkers in the early diagnosis of AD.

摘要

本研究旨在探讨微小RNA(miR)-4722-5p和miR-615-3p在阿尔茨海默病(AD)中的表达水平及其诊断价值。收集了33例AD患者和33名健康对照者的血液样本,并建立了β-淀粉样蛋白(Aβ)25-35诱导的PC12细胞模型。采用逆转录定量PCR检测miR-4722-5p和miR-615-3p的相对mRNA表达水平。分析了这两种微小RNA的mRNA表达水平与简易精神状态检查表(MMSE)评分之间的相关性,并使用受试者工作特征曲线评估miR-4722-5p和miR-615-3p在AD中的诊断价值。使用注释、可视化和综合发现数据库以及R语言分析包对微小RNA靶基因进行功能富集分析。在AD患者和Aβ25-35诱导的PC12细胞模型中,miR-4722-5p和miR-615-3p的mRNA表达水平升高。miR-4722-5p和miR-615-3p的mRNA表达水平与MMSE评分呈负相关,两种微小RNA联合用于AD诊断的价值优于单独使用每种微小RNA。基因本体论(GO)富集分析结果显示,miR-4722-5p的靶基因存在于细胞质和胞质溶胶中,主要参与蛋白质折叠和细胞分裂。分子功能包括蛋白质结合和GTP酶激活剂活性。京都基因与基因组百科全书分析结果显示,miR-4722-5p与多巴胺能突触和mTOR信号通路的调节有关。GO富集分析还显示,miR-615-3p的靶基因位于细胞核和细胞质中,参与转录和蛋白质磷酸化的调节,并与蛋白质结合、金属离子结合和转录因子活性有关。miR-615-3p的靶基因在Ras和FoxO信号通路的调节中起重要作用。总之,miR-4722-5p和miR-615-3p可能是AD早期诊断的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/a232db7a6c90/etm-23-03-11166-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/96898d9db756/etm-23-03-11166-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/355004afe98c/etm-23-03-11166-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/f0b431b106ac/etm-23-03-11166-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/3909893f24fe/etm-23-03-11166-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/a232db7a6c90/etm-23-03-11166-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/96898d9db756/etm-23-03-11166-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/355004afe98c/etm-23-03-11166-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/f0b431b106ac/etm-23-03-11166-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/3909893f24fe/etm-23-03-11166-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a498/8815048/a232db7a6c90/etm-23-03-11166-g04.jpg

相似文献

1
MicroRNA-4722-5p and microRNA-615-3p serve as potential biomarkers for Alzheimer's disease.微小RNA-4722-5p和微小RNA-615-3p可作为阿尔茨海默病的潜在生物标志物。
Exp Ther Med. 2022 Mar;23(3):241. doi: 10.3892/etm.2022.11166. Epub 2022 Jan 26.
2
Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease.尿外泌体微小RNA-145-5p和微小RNA-27a-3p作为糖尿病肾病的非侵入性诊断生物标志物。
World J Diabetes. 2024 Jan 15;15(1):92-104. doi: 10.4239/wjd.v15.i1.92.
3
MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.微小RNA-455-3p作为阿尔茨海默病潜在的外周生物标志物
Hum Mol Genet. 2017 Oct 1;26(19):3808-3822. doi: 10.1093/hmg/ddx267.
4
Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.血清 microRNA miR-501-3p 作为与阿尔茨海默病进展相关的潜在生物标志物。
Acta Neuropathol Commun. 2017 Jan 31;5(1):10. doi: 10.1186/s40478-017-0414-z.
5
MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.用于从公共数据中识别阿尔茨海默病血液生物标志物的MicroRNA测序数据分析流程
Biomark Insights. 2015 Apr 15;10:21-31. doi: 10.4137/BMI.S25132. eCollection 2015.
6
Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?外周血微小RNA表达数据能否作为阿尔茨海默病的表观基因组(上游)生物标志物?
OMICS. 2016 Aug;20(8):456-61. doi: 10.1089/omi.2016.0099.
7
Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN.miR-193a-3p 在阿尔茨海默病中的诊断价值及 miR-193a-3p 通过靶向 PTEN 减轻淀粉样β诱导的神经毒性
Exp Gerontol. 2020 Feb;130:110814. doi: 10.1016/j.exger.2019.110814. Epub 2019 Dec 16.
8
Circulating exosomal miRNAs as novel biomarkers for acute aortic dissection: A diagnostic accuracy study.循环外泌体 miRNA 作为急性主动脉夹层的新型生物标志物:一项诊断准确性研究。
Medicine (Baltimore). 2023 Jul 28;102(30):e34474. doi: 10.1097/MD.0000000000034474.
9
Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.一个携带 PSEN1 G378E 突变的中国家庭的 microRNA 谱的对比研究。
Metab Brain Dis. 2018 Oct;33(5):1711-1720. doi: 10.1007/s11011-018-0279-2. Epub 2018 Jul 1.
10
Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.血清中三microRNA 标志物 panel 用于诊断新生儿早发型败血症的研究。
J Matern Fetal Neonatal Med. 2023 Dec;36(2):2280527. doi: 10.1080/14767058.2023.2280527. Epub 2023 Nov 15.

引用本文的文献

1
Determination of Differential miRNA Expression Profile in People with Noise-Induced Hearing Loss.噪声性听力损失患者中差异微小RNA表达谱的测定
Int J Mol Sci. 2025 Jul 10;26(14):6623. doi: 10.3390/ijms26146623.
2
Blood-based microRNAs as the potential biomarkers for Alzheimer's disease: evidence from a systematic review.基于血液的 microRNAs 作为阿尔茨海默病的潜在生物标志物:系统评价的证据。
Metab Brain Dis. 2024 Nov 28;40(1):44. doi: 10.1007/s11011-024-01431-7.
3
Potential Application of MicroRNAs and Some Other Molecular Biomarkers in Alzheimer's Disease.

本文引用的文献

1
Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease.阿尔茨海默病转基因模型中的氧化应激、免疫反应、突触可塑性和认知。
Neurologia (Engl Ed). 2022 Oct;37(8):682-690. doi: 10.1016/j.nrleng.2019.06.008. Epub 2021 Sep 9.
2
Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer's Disease: Current Perspectives and Challenging Prospects.抗癌表皮生长因子受体抑制剂在阿尔茨海默病中的潜在重新定位:当前观点与挑战性前景
Neuroscience. 2021 Aug 10;469:191-196. doi: 10.1016/j.neuroscience.2021.06.013. Epub 2021 Jun 15.
3
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer's Disease.
微小RNA及其他一些分子生物标志物在阿尔茨海默病中的潜在应用
Curr Issues Mol Biol. 2024 May 22;46(6):5066-5084. doi: 10.3390/cimb46060304.
4
Noncoding RNAs in Alzheimer's Disease: Overview of Functional and Therapeutic Significance.非编码 RNA 在阿尔茨海默病中的作用:功能与治疗意义概述。
Curr Top Med Chem. 2024;24(19):1615-1634. doi: 10.2174/0115680266293212240405042540.
5
Exosomal Circular Ribonucleic Acid-Microribonucleic Acid Expression Profile from Plasma in Alzheimer's Disease Patients by Bioinformatics and Integrative Analysis.通过生物信息学和综合分析对阿尔茨海默病患者血浆中外泌体环状核糖核酸-微小核糖核酸表达谱的研究
Eurasian J Med. 2023 Oct;55(3):218-227. doi: 10.5152/eurasianjmed.2023.23029.
6
Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration.脑警报:自身细胞外核酸引发的神经炎症到神经退行性变。
J Biomed Sci. 2023 Aug 7;30(1):64. doi: 10.1186/s12929-023-00954-y.
7
Cognitive Impairment in Multiple Sclerosis.多发性硬化症中的认知障碍
Bioengineering (Basel). 2023 Jul 23;10(7):871. doi: 10.3390/bioengineering10070871.
8
State of the Art of microRNAs Signatures as Biomarkers and Therapeutic Targets in Parkinson's and Alzheimer's Diseases: A Systematic Review and Meta-Analysis.作为帕金森病和阿尔茨海默病生物标志物及治疗靶点的微小RNA特征研究现状:一项系统综述与荟萃分析
Biomedicines. 2023 Apr 7;11(4):1113. doi: 10.3390/biomedicines11041113.
9
Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.近年来 microRNA 及其在神经退行性疾病中的诊断作用的研究进展。
Biosensors (Basel). 2022 Nov 24;12(12):1074. doi: 10.3390/bios12121074.
10
Context-Dependent Regulation of Gene Expression by Non-Canonical Small RNAs.非经典小RNA对基因表达的上下文依赖性调控
Noncoding RNA. 2022 Apr 29;8(3):29. doi: 10.3390/ncrna8030029.
血清miR-128可作为阿尔茨海默病的潜在诊断生物标志物。
Neuropsychiatr Dis Treat. 2021 Jan 29;17:269-275. doi: 10.2147/NDT.S290925. eCollection 2021.
4
A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients.一项纵向研究将循环微RNA定义为肌萎缩侧索硬化症(ALS)患者疾病预后和进展的可靠生物标志物。
Cell Death Discov. 2021 Jan 11;7(1):4. doi: 10.1038/s41420-020-00397-6.
5
Long noncoding RNA Nespas inhibits apoptosis of epileptiform hippocampal neurons by inhibiting the PI3K/Akt/mTOR pathway.长链非编码 RNA Nespas 通过抑制 PI3K/Akt/mTOR 通路抑制癫痫样海马神经元凋亡。
Exp Cell Res. 2021 Jan 1;398(1):112384. doi: 10.1016/j.yexcr.2020.112384. Epub 2020 Nov 17.
6
Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach.利用基因共表达网络方法在阿尔茨海默病不同阶段进行基因生物标志物发现。
Sci Rep. 2020 Jul 22;10(1):12210. doi: 10.1038/s41598-020-69249-8.
7
Serum FOXO3A: A ray of hope for early diagnosis of Alzheimer's disease.血清 FOXO3A:阿尔茨海默病早期诊断的一线希望。
Mech Ageing Dev. 2020 Sep;190:111290. doi: 10.1016/j.mad.2020.111290. Epub 2020 Jun 27.
8
Soluble SORLA Enhances Neurite Outgrowth and Regeneration through Activation of the EGF Receptor/ERK Signaling Axis.可溶性 SORLA 通过激活 EGF 受体/ERK 信号通路增强神经突生长和再生。
J Neurosci. 2020 Jul 29;40(31):5908-5921. doi: 10.1523/JNEUROSCI.0723-20.2020. Epub 2020 Jun 29.
9
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease.阿尔茨海默病患者血浆神经来源的小细胞外囊泡中的 miRNA 谱分析。
Cells. 2020 Jun 10;9(6):1443. doi: 10.3390/cells9061443.
10
Mechanism of microRNA-22 in regulating neuroinflammation in Alzheimer's disease.miRNA-22 在调控阿尔茨海默病神经炎症中的作用机制。
Brain Behav. 2020 Jun;10(6):e01627. doi: 10.1002/brb3.1627. Epub 2020 Apr 19.